genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Horizon Therapeutics
Drug Discovery
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Alex Philippidis
-
October 3, 2023
0
Bioprocessing
Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Alex Philippidis
-
September 21, 2023
0
Drug Discovery
StockWatch: FTC vs. Amgen-Horizon Could Slam Brakes on Biotech M&A
Alex Philippidis
-
May 17, 2023
18
Drug Discovery
Amgen Vows to Fight Back as FTC Takes Aim at $27.8B Horizon Deal
Alex Philippidis
-
May 16, 2023
28
Scroll Up